Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats.

Abstract

1. Vanadium compounds can mimic actions of insulin through alternative signalling pathways. The effects of three organic vanadium compounds were studied in non-ketotic, streptozotocin-diabetic rats: vanadyl acetylacetonate (VAc), vanadyl 3-ethylacetylacetonate (VEt), and bis(maltolato)oxovanadium (VM). A simple inorganic vanadium salt, vanadyl sulphate (VS) was also studied. 2. Oral administration of the three organic vanadium compounds (125 mg vanadium element 1(-1) in drinking fluids) for up to 3 months induced a faster and larger fall in glycemia (VAc being the most potent) than VS. Glucosuria and tolerance to a glucose load were improved accordingly. 3. Activities and mRNA levels of key glycolytic enzymes (glucokinase and L-type pyruvate kinase) which are suppressed in the diabetic liver, were restored by vanadium treatment. The organic forms showed greater efficacy than VS, especially VAc. 4. VAc rats exhibited the highest levels of plasma or tissue vanadium, most likely due to a greater intestinal absorption. However, VAc retained its potency when given as a single i.p. injection to diabetic rats. Moreover, there was no relationship between plasma or tissue vanadium levels and any parameters of glucose homeostasis and hepatic glucose metabolism. Thus, these data suggest that differences in potency between compounds are due to differences in their insulin-like properties. 5. There was no marked toxicity observed on hepatic or renal function. However, diarrhoea occurred in 50% of rats chronically treated with VS, but not in those receiving the organic compounds. 6. In conclusion, organic vanadium compounds, in particular VAc, correct the hyperglycemia and impaired hepatic glycolysis of diabetic rats more safely and potently than VS. This is not simply due to improved intestinal absorption, indicating more potent insulin-like properties.

• Authors: B A Reul, S S Amin, J P Buchet, L N Ongemba, D C Crans, S M Brichard
• Journal: British journal of pharmacology (Br J Pharmacol) Vol. 126 Issue 2 Pg. 467-77 (Jan 1999) ISSN: 0007-1188 [Print] England
• PMID: 10077240 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)

Chemical References

• Blood Glucose
• Disinfectants
• Hydroxybutyrates
• Hypoglycemic Agents
• Insulin
• Ligands
• Liver Glycogen
• Organometallic Compounds
• Pentanones
• Pyrones
• RNA, Messenger
• Vanadium Compounds
• vanadyl-3-ethylacetylacetonate
• acetyl acetonate
• bis(maltolato)oxovanadium(IV)
• Vanadates
• vanadyl sulfate
• Glucokinase
• Pyruvate Kinase
• Phosphoenolpyruvate Carboxykinase (GTP)
• Glucose

Topics

• Administration, Oral
• Animals
• Blood Glucose (drug effects, metabolism)
• Body Weight (drug effects)
• Diabetes Mellitus, Experimental (metabolism)
• Disinfectants (pharmacology)
• Glucokinase (drug effects, genetics, metabolism)
• Glucose (metabolism)
• Hydroxybutyrates (chemistry, pharmacology)
• Hypoglycemic Agents (pharmacology)
• Injections, Intraperitoneal
• Insulin (metabolism)
• Islets of Langerhans (drug effects, metabolism)
• Ligands
• Liver (drug effects, metabolism)
• Liver Glycogen (metabolism)
• Male
• Muscles (drug effects, metabolism)
• Organometallic Compounds (pharmacology)
• Pentanones (chemistry, pharmacology)
• Phosphoenolpyruvate Carboxykinase (GTP) (drug effects, genetics, metabolism)
• Pyrones (chemistry, pharmacology)
• Pyruvate Kinase (drug effects, genetics, metabolism)
• RNA, Messenger (drug effects, genetics)
• Rats
• Rats, Wistar
• Time Factors
• Vanadates (chemistry, pharmacology)
• Vanadium Compounds (chemistry, pharmacology)